Your browser doesn't support javascript.
COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.
Abutiban, Fatemah; Saleh, Khulood; Hayat, Sawsan; Tarakmah, Hoda; Al-Herz, Adeeba; Ghanem, Aqeel.
  • Abutiban F; Department of Medicine, Jaber Alahmed Hospital, Ministry of Health, Kuwait City, Kuwait.
  • Saleh K; Department of Medicine, Farwaniyah Hospital, Ministry of Health, Kuwait City, Kuwait.
  • Hayat S; Department of Medicine, Mubarak Alkabeer Hospital, Ministry of Health, Kuwait City, Kuwait.
  • Tarakmah H; Department of Medicine, Mubarak Alkabeer Hospital, Ministry of Health, Kuwait City, Kuwait.
  • Al-Herz A; Department of Medicine, AlAmiri Hospital, Ministry of Health, Kuwait City, Kuwait.
  • Ghanem A; Department of Medicine, Mubarak Alkabeer Hospital, Ministry of Health, Kuwait City, Kuwait.
Int J Rheum Dis ; 25(7): 743-754, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-1840300
ABSTRACT

PURPOSE:

We aimed to assess the characteristics of inflammatory rheumatic disease (IRD) patients in Kuwait diagnosed with COVID-19 and the factors linked with hospitalization, complications, and mortality.

METHODS:

Data of IRD patients from Kuwait diagnosed with COVID-19 between March 2020 and March 2021, submitted to the COVID-19 Global Rheumatology Alliance physician-reported registry, were included in our analysis. Data on patients' age, gender, smoking, diagnosis, IRD activity, and other comorbidities were collected. Statistical Package for the Social Sciences (SPSS), version 25, was used for statistical analysis.

RESULTS:

A total of 52 patients were included, with a mean age of 55 years (±14). The majority of patients were ≤65 years (77%), female (77%), non-smokers (80.8%), and diagnosed with rheumatoid arthritis (67.0%). Of the included patients, 19.2%, 9.6%, and 7.7% reported having methotrexate monotherapy, antimalarials monotherapy, and interleukin-6 inhibitors monotherapy immediately before COVID-19, respectively. Most of the included patients (92.3%) were either in remission or had minimal/low disease activity, while others (7.7%) had moderate disease activity. Forty-three patients (82.7%) were hospitalized, while 11 patients (25.6%) required ventilation (invasive or non-invasive). Ten of the ventilated patients (90.9%) received glucocorticoids as part of the local protocol to treat severe COVID symptoms, and 4 patients (7.69%) died. The duration till symptom-free ranged between 0 to 30 days, with a mean value of 10 days (±6.5).

CONCLUSION:

The current study provides timely real-world evidence regarding characteristics and potential risk factors linked to poor COVID-19-related outcomes in the IRD population in Kuwait.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Physicians / Rheumatology / Rheumatic Diseases / Antirheumatic Agents / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Female / Humans / Middle aged Country/Region as subject: Asia Language: English Journal: Int J Rheum Dis Journal subject: Rheumatology Year: 2022 Document Type: Article Affiliation country: 1756-185X.14332

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Physicians / Rheumatology / Rheumatic Diseases / Antirheumatic Agents / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Female / Humans / Middle aged Country/Region as subject: Asia Language: English Journal: Int J Rheum Dis Journal subject: Rheumatology Year: 2022 Document Type: Article Affiliation country: 1756-185X.14332